Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cazenave

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
Soins. Psychiatrie|November 1, 1989
[In search of lost dignity]P Cazenave
La Revue Du Praticien|February 1, 1981
[Platelet-vessel interactions]J P Cazenave
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[In vivo and invitro methods of studying platelet adhesion to the components of the vascular wall]J P Cazenave
Annales De Biologie Clinique|January 1, 1987
[Role of blood platelets in thrombosis of the arteries and artificial surfaces]J P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2011
[Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety]J-P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 2, 2011
[Pathogen inactivation in platelet concentrates: the French experience]J-P Cazenave
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[In vivo and in vitro methods of studying platelet adhesion to the components of the vascular wall]J P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 25, 2007
[Bacterial contamination: should it be detected or inactivated?]J-P Cazenave
Thrombosis and Haemostasis|August 30, 1985
Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregationF Lanza, J P Cazenave
Hematology and Cell Therapy|May 1, 1996
Management of plasmapheresis in FranceJ P Cazenave, G Folléa
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
Soins. Psychiatrie|November 1, 1989
[In search of lost dignity]P Cazenave
La Revue Du Praticien|February 1, 1981
[Platelet-vessel interactions]J P Cazenave
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[In vivo and invitro methods of studying platelet adhesion to the components of the vascular wall]J P Cazenave
Annales De Biologie Clinique|January 1, 1987
[Role of blood platelets in thrombosis of the arteries and artificial surfaces]J P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 9, 2011
[Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety]J-P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 2, 2011
[Pathogen inactivation in platelet concentrates: the French experience]J-P Cazenave
Nouvelle Revue Francaise D'Hematologie|January 1, 1979
[In vivo and in vitro methods of studying platelet adhesion to the components of the vascular wall]J P Cazenave
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 25, 2007
[Bacterial contamination: should it be detected or inactivated?]J-P Cazenave
Thrombosis and Haemostasis|August 30, 1985
Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregationF Lanza, J P Cazenave
Hematology and Cell Therapy|May 1, 1996
Management of plasmapheresis in FranceJ P Cazenave, G Folléa
Pageof 39